Search results for "Lipide"

showing 10 items of 532 documents

Familial Hypercholesterolemia and Lipoprotein(a): A Gordian Knot in Cardiovascular Prevention

2022

Familial hypercholesterolemia (FH) is the most frequent genetic disorder resulting in increased low-density lipoprotein cholesterol (LDL-C) levels from childhood, leading to premature atherosclerotic cardiovascular disease (ASCVD) if left untreated. FH diagnosis is based on clinical criteria and/or genetic testing and its prevalence is estimated as being up to 1:300,000-400,000 for the homozygous and similar to 1:200-300 for the heterozygous form. Apart from its late diagnosis, FH is also undertreated, despite the available lipid-lowering therapies. In addition, elevated lipoprotein(a) (Lp(a)) (>50 mg/dL; 120 nmol/L), mostly genetically determined, has been identified as an important car…

Endocrinology Diabetes and MetabolismMolecular BiologyBiochemistrycardiovascular disease cholesterol familial hypercholesterolemia hypolipidemic treatment lipoprotein(a)
researchProduct

The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?

2008

The metabolic syndrome consists of a constellation of clinical and biochemical risk factors that cluster together and heighten the risk for atherogenesis, cardiovascular diseases, and diabetes. Established risk cardiovascular factors like hypertension, atherogenic dyslipidaemia, and glucose intolerance occur in the setting of insulin resistance and central adiposity, with genetic and environmental influences modulating the ultimate risk. Chronic insults to the endothelium take its toll in the form of silent as well as clinically evident cardiovascular events. The cellular and vascular accompaniments have shed some light into the underlying pathophysiology. Heightened, low-grade inflammatory…

Endocrinology Diabetes and Metabolismmedicine.medical_treatmentInflammationMetabolic syndrome Insulin resistance Dyslipidemia Atherosclerosis Adipocytokinesmedicine.disease_causeTargeted therapyEndocrinologyInsulin resistanceRisk FactorsDiabetes mellitusHeredityInternal MedicinemedicineHumansClinical significanceDyslipidemiasInflammationMetabolic Syndromebusiness.industryCholesterol LDLGeneral MedicineAtherosclerosismedicine.diseaseC-Reactive ProteinImmunologymedicine.symptomMetabolic syndromebusinessBiomarkersDyslipidemiaActa Diabetologica
researchProduct

Effect of the lipid regulator Gemfibrozil in the Cladocera Daphnia magna at different temperatures.

2016

ABSTRACTIn the present study, an ecotoxicological approach to the evaluation of Gemfibrozil (GEM) as an emerging organic pollutant was done. In order to assess its toxicity, tests were conducted using the cladocera Daphnia magna. Experiments were carried out at 22°C and 28°C. EC50, feeding behavior, and chronic toxicity tests (21 days) were evaluated in D. magna exposed to GEM as well as cholesterol levels at 21-day chronic exposure. D. magna GEM EC50 values (24 h) in our experimental conditions were 148.75 and 116.24 mg L−1 at 22°C and 28°C, respectively. Test concentrations of 0.1, 0.5, 1.0, 5.0 and 7.5 mg L−1 were selected for subacute and chronic experiments. Subacute short-term test (f…

Environmental EngineeringDaphnia magna010501 environmental sciences01 natural sciencesToxicologyLethal Dose 5003 medical and health scienceschemistry.chemical_compound0302 clinical medicineAnimal sciencemedicineGemfibrozilIngestionAnimalsToxicity Tests ChronicChronic toxicity0105 earth and related environmental sciencesEC50Hypolipidemic AgentsbiologyReproductionTemperatureGeneral MedicineFeeding Behaviorbiology.organism_classificationCladocerachemistryDaphnia030220 oncology & carcinogenesisToxicityFemaleGemfibrozilWater Pollutants Chemicalmedicine.drugToxicantJournal of environmental science and health. Part A, Toxic/hazardous substancesenvironmental engineering
researchProduct

Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil

1999

The drug residues of lipid regulators, anti-inflammatories and some drug metabolites have been detected in raw sewage, treated waste water and river water in the state of Rio de Janeiro, Brazil. These residues are mainly derived from humans via excretion. The median concentrations in the effluents of sewage treatment plants (STPs) of most drugs investigated in this study ranged from 0.1 to 1 microgram/l. The removal rates of individual drugs during passage through a Brazilian STP varied from 12 to 90%. As a consequence of the incomplete removal of these residues during passage through a STP, rivers were also found to be contaminated. Median concentrations ranged from between 0.02 and 0.04 m…

Environmental EngineeringDrug-Related Side Effects and Adverse ReactionsAnti-Inflammatory AgentsSewageFresh WaterEnvironmental pollutionRisk AssessmentAnimalsHumansEnvironmental ChemistryWater pollutionWaste Management and DisposalEffluentHypolipidemic AgentsSewageChemistrybusiness.industryEnvironmental engineeringPollutionPharmaceutical PreparationsWastewaterEnvironmental chemistrySewage treatmentWater qualityEnvironmental PollutionbusinessSurface waterBrazilWater Pollutants ChemicalScience of The Total Environment
researchProduct

Diverse compounds mimic Alzheimer disease–causing mutations by augmenting Aβ42 production

2004

Increased Abeta42 production has been linked to the development of Alzheimer disease. We now identify a number of compounds that raise Abeta42. Among the more potent Abeta42-raising agents identified are fenofibrate, an antilipidemic agent, and celecoxib, a COX-2-selective NSAID. Many COX-2-selective NSAIDs tested raised Abeta42, including multiple COX-2-selective derivatives of two Abeta42-lowering NSAIDs. Compounds devoid of COX activity and the endogenous isoprenoids FPP and GGPP also raised Abeta42. These compounds seem to target the gamma-secretase complex, increasing gamma-secretase-catalyzed production of Abeta42 in vitro. Short-term in vivo studies show that two Abeta42-raising comp…

Enzyme-Linked Immunosorbent AssayEndogenyProtein Serine-Threonine KinasesPharmacologyTransfectionMass SpectrometryGeneral Biochemistry Genetics and Molecular BiologyPresenilinCell LineFenofibrateAlzheimer DiseaseIn vivoEndopeptidasesmedicineAspartic Acid EndopeptidasesHumansImmunoprecipitationCyclooxygenase InhibitorsProtein precursorHypolipidemic AgentsSulfonamidesrho-Associated KinasesAmyloid beta-PeptidesFenofibratebusiness.industryAnti-Inflammatory Agents Non-SteroidalIntracellular Signaling Peptides and ProteinsBrainGeneral Medicinemedicine.diseaseIn vitroEnzyme ActivationBiochemistryCelecoxibPyrazolesFemaleAmyloid Precursor Protein SecretasesAlzheimer's diseaserhoA GTP-Binding ProteinbusinessAntilipidemic Agentmedicine.drugNature Medicine
researchProduct

Obesity and Cardiometabolic Risk Factors : from Childhood to Adulthood

2021

Obesity has become a major epidemic in the 21st century. It increases the risk of dyslipidemia, hypertension, and type 2 diabetes, which are known cardiometabolic risk factors and components of the metabolic syndrome. Although overt cardiovascular (CV) diseases such as stroke or myocardial infarction are the domain of adulthood, it is evident that the CV continuum begins very early in life. Recognition of risk factors and early stages of CV damage, at a time when these processes are still reversible, and the development of prevention strategies are major pillars in reducing CV morbidity and mortality in the general population. In this review, we will discuss the role of well-known but also …

EpigenomicsMaleGerontologyPediatric ObesityobesityInfants Alimentacióobesity ; cardiometabolic risk factors ; hypertension ; dyslipidemia ; tracking phenomenon ; nutrigenomicsReviewType 2 diabetesnutrigenomicPregnancytracking phenomenon.TX341-641ChildPrenatal Nutritional Physiological PhenomenaMetabolic Syndromeeducation.field_of_studyNutrition and Dieteticscardiometabolic risk factorNutrigenomicsCardiorespiratory FitnessCardiovascular DiseasesChild PreschoolObesitatFemaleAdulttracking phenomenonhypertensionAdolescentPopulationChildhood obesityYoung AdultnutrigenomicsmedicineMortalitatHumansAdultseducationbusiness.industryNutrition. Foods and food supplydyslipidemiaInfant NewbornInfantCardiorespiratory fitnessmedicine.diseaseObesitycardiometabolic risk factorsDietMetabolic syndromebusinessDyslipidemiaFood Science
researchProduct

Microsomal and cytosolic epoxide hydrolases, the peroxisomal fatty acid beta-oxidation system and catalase. Activities, distribution and induction in…

1988

A number of structurally unrelated hypolipidaemic agents and certain phthalate-ester plasticizers induce hepatomegaly and proliferation of peroxisomes in rodent liver, but there is relatively limited data regarding the specific effects of these drugs on liver non-parenchymal cells. In the present study, liver parenchymal, Kupffer and endothelial cells from untreated and fenofibrate-fed rats were isolated and the activities of two enzymes associated with peroxisomes (catalase and the peroxisomal fatty acid beta-oxidation system) as well as cytosolic and microsomal epoxide hydrolase were measured. Microsomal epoxide hydrolase, cytosolic epoxide hydrolase and catalase activities were 7-12-fold…

Epoxide hydrolase 2MaleKupffer CellsBiologyFatty acid beta-oxidationBiochemistryMicrobodiesCytosolFenofibrateMicrobodyAnimalsEndotheliumEpoxide hydrolaseHypolipidemic Agentschemistry.chemical_classificationEpoxide HydrolasesFatty AcidsFatty acidRats Inbred StrainsPeroxisomeCatalaseRatschemistryBiochemistryLiverMicrosomal epoxide hydrolaseEpoxide HydrolasesMicrosomes LiverPropionatesOxidation-ReductionEuropean journal of biochemistry
researchProduct

Red blood cell distribution width: A simple parameter with multiple clinical applications

2014

The red blood cell distribution width (RDW) is a simple and inexpensive parameter, which reflects the degree of heterogeneity of erythrocyte volume (conventionally known as anisocytosis), and is traditionally used in laboratory hematology for differential diagnosis of anemias. Nonetheless, recent evidence attests that anisocytosis is commonplace in human disorders such as cardiovascular disease, venous thromboembolism, cancer, diabetes, community-acquired pneumonia, chronic obstructive pulmonary disease, liver and kidney failure, as well as in other acute or chronic conditions. Despite some demographic and analytical issues related to the routine assessment that may impair its clinical usef…

Erythrocyte Indicesmedicine.medical_specialtyClinical BiochemistryPopulationDiseaseErythrocyte homeostasisBioinformaticsGeneral Biochemistry Genetics and Molecular BiologyRisk FactorsInternal medicineDiabetes mellitusmedicineHumansRDWeducationErythrocyte Volumeeducation.field_of_studyHematologybusiness.industryBiochemistry (medical)Red blood cell distribution widthHematologyPrognosismedicine.diseasemortalityrisk factorImmunologyAnisocytosisHematology; RDW; mortality; red blood cell distribution width; risk factorred blood cell distribution widthbusinessDyslipidemiaCritical Reviews in Clinical Laboratory Sciences
researchProduct

Narkoprobleemide kajastamine Eesti ajakirjanduses (1993-2009)

2013

EstoniahuumeetViropost-socialist transitionmedia representationmedia framespoliittinen muutosillicit drugschangespostkommunismiyleinen mielipide"issue-attention cycle"vaikuttaminenhuumepolitiikkapressjournalistiikkaaddictionlehdistöyhteiskunnallinen muutosdrug policySisällönanalyysiLähilukuviestintämediatutkimusvaikutusvalta
researchProduct

Mediterranean diet adherence and synergy with acute myocardial infarction and its determinants: A multicenter case-control study in Italy

2018

Background Cardiovascular diseases are the leading causes of mortality and morbidity in Western countries. The possible synergistic effect of poor adherence to a Mediterranean diet (MD) and other risk factors for acute myocardial infarction (AMI) such as hypertension, cholesterol, ever smoker, BMI> 25, diabetes, has not been deeply studied. Design Case-control study. Methods Patients with first AMI and controls from four tertiary referral Italian centers were screened for enrolment. Dietary information was collected through a questionnaire and a MD adherence score was calculated. Physical activity and smoking habits were also registered. The Synergy Index was calculated according to Rothman…

Genetics and Molecular Biology (all)MaleMultivariate analysisMediterranean dietTertiary Care CenterMyocardial Infarctionlcsh:MedicineBlood PressureMediterranean030204 cardiovascular system & hematologyPathology and Laboratory MedicineDiet MediterraneanVascular MedicineBiochemistryGeographical locationsTertiary Care CentersHabitschemistry.chemical_compoundEndocrinology0302 clinical medicineRisk FactorsSurveys and QuestionnairesMedicine and Health SciencesSmoking HabitsSurveys and Questionnaire030212 general & internal medicineMyocardial infarctionlcsh:ScienceMultidisciplinarySmokingMiddle AgedEuropeHyperlipidemiaItalyResearch DesignSettore MED/42HypertensionFemaleCase-Control StudieHumanResearch Articlemedicine.medical_specialtyAged; Case-Control Studies; Feeding Behavior; Female; Humans; Hypertension; Italy; Male; Middle Aged; Myocardial Infarction; Risk Factors; Smoking; Surveys and Questionnaires; Tertiary Care Centers; Diet Mediterranean; Patient ComplianceReferralEndocrine DisordersSmoking habitHypercholesterolemiaCardiologyResearch and Analysis Methods03 medical and health sciencesSigns and SymptomsDiagnostic MedicineDiabetes mellitusInternal medicineDiabetes MellitusAged; Case-Control Studies; Feeding Behavior; Female; Humans; Hypertension; Italy; Male; Middle Aged; Myocardial Infarction; Risk Factors; Smoking; Surveys and Questionnaires; Tertiary Care Centers; Diet Mediterranean; Patient Compliance; Biochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)medicineHumansEuropean UnionNutritionAgedBehaviorCholesterolbusiness.industryRisk Factorlcsh:RCase-control studyBiology and Life SciencesFeeding Behaviormedicine.diseaseDietAgricultural and Biological Sciences (all)chemistryMetabolic DisordersCase-Control StudiesPatient Compliancelcsh:QPeople and placesbusinessPLOS ONE
researchProduct